Logo-ipp

Original

1. The prevalence of COVID-19 in patients with rheumatoid arthritis, multiple sclerosis, or systemic lupus erythematosus receiving biologic disease-modifying antirheumatic drugs
Arman Ahmadzadeh ORCID, Faraneh Farsad ORCID, Mohammad Mehdi Emam ORCID, Alireza Rajaei ORCID, Samaneh Hatami* ORCID, Latif Gachkar ORCID
Immunopathol Persa. 2021;7(2): e35. doi: 10.34172/ipp.2021.35
Scopus ID: 85112541938    
Article
PDF
XML
Cited By:
0
0